Clinical Trial Update: Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing lixisenatide with sitagliptin, both in combination with insulin glargine, evaluating postprandial glucose in type 2 diabetes. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Lixisenatide (lixisenatide)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED